ICVX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 30.59%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $229,350.00

Icosavax Insider Trading History Chart

This chart shows the insider buying and selling history at Icosavax by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Icosavax Share Price & Price History

Current Price: $15.31
Price Change: +0.30 (1.20%)
As of 02/20/2024 01:00 AM ET

This chart shows the closing price history over time for ICVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Icosavax (NASDAQ:ICVX)

92.59% of Icosavax stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ICVX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$60M-$40M-$20M$0$20M$40M$60MTotal InflowsTotal Outflows
Icosavax logo
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc. operates as a subsidiary of AstraZeneca PLC.
Read More on Icosavax

Today's Range

Now: $15.31
Low: $15.31
High: $15.31

50 Day Range

MA: $15.32
Low: $15.31
High: $15.45

52 Week Range

Now: $15.31
Low: $4.75
High: $16.10

Volume

N/A

Average Volume

1,215,776 shs

Market Capitalization

$766.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of Icosavax?

Icosavax's top insider investors include:
  1. Adam K Simpson (CEO)
  2. Douglas Holtzman (Insider)
  3. Niranjan Kanesa-Thasan (Insider)
  4. Cassia Cearley (Insider)
  5. Elizabeth Bekiroglu (General Counsel)
  6. Thomas Joseph Russo (CFO)
Learn More about top insider investors at Icosavax.